ADCT stock results show that ADC Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. More
Articles
ENFN Stock Earnings: Enfusion Misses EPS, Misses Revenue for Q2 2024
ENFN stock results show that Enfusion missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. More
SRE Stock Earnings: Sempra Misses EPS, Misses Revenue for Q2 2024
SRE stock results show that Sempra missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. More
3 Under-the-Radar Tech Stocks Primed for Explosive Growth
Under-the-radar tech stocks are well positioned to grow investor capital through innovation and untapped value in the market. More
Barclays Just Raised Its Price Target on These 3 Stocks: August 2024
One of the best ways to spot opportunity is by keeping tabs on stocks with raised price targets from leading firms like Barclays. More
Lumen Technologies News: What Is Going On With LUMN Stock Today?
Lumen Technologies is surging today on news of multiple new AI deals. Here's why LUMN stock looks like a new AI winner. More
FuboTV News: Why Is FUBO Stock Moving Today?
FuboTV stock is down on Tuesday as investors in FUBO react to the company's latest earnings report and guidance. More